gms | German Medical Science

27th German Cancer Congress Berlin 2006

German Cancer Society (Frankfurt/M.)

22. - 26.03.2006, Berlin

Integration of psycho-oncological diagnostics during cancer treatment within the context of tumorboard meetings at a comprehensive cancer centre*

Meeting Abstract

  • corresponding author presenting/speaker Birgit Huber - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Medizinische Psychologie, Klinikum rechts der Isar, TU München, Deutschland
  • Pia Heussner - Medizinische Klinik und Poliklinik III, Klinikum Großhadern, Ludwig-Maximilians-Universität, München
  • Gerhard Henrich - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Medizinische Psychologie, Klinikum rechts der Isar, TU München
  • Kathrin Siewert - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Medizinische Psychologie, Klinikum rechts der Isar, TU München
  • Celia Pirker - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Medizinische Psychologie, Klinikum rechts der Isar, TU München
  • Peter Herschbach - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Medizinische Psychologie, Klinikum rechts der Isar, TU München
  • Almuth Sellschopp - Institut und Poliklinik für Psychosomatische Medizin, Psychotherapie und Medizinische Psychologie, Klinikum rechts der Isar, TU München

27. Deutscher Krebskongress. Berlin, 22.-26.03.2006. Düsseldorf, Köln: German Medical Science; 2006. DocPE593

The electronic version of this article is the complete one and can be found online at: http://www.egms.de/en/meetings/dkk2006/06dkk701.shtml

Published: March 20, 2006

© 2006 Huber et al.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by-nc-nd/3.0/deed.en). You are free: to Share – to copy, distribute and transmit the work, provided the original author and source are credited.


Outline

Text

Psychosocial aspects of care have already been integrated into the treatment of cancer patients in many centres worldwide and thus are taken for granted in daily routine. Regrettably, interventions are often carried out without prior systematic psycho-oncological diagnostics. Therefore our project intended to implement a psycho-oncological screening for medical doctors in the clinical routine, to detect patients with a high amount of psychosocial stress at an early point of time in treatment. In our project patients filled in a selection of self-assessment questionnaires (EORTC QLQ-C30, HADS, FPZ) at the time of admission and after discharge from hospital. With a short questionnaire (Psychoonkologische Kurzeinschätzung, PO-K) the doctors assessed a distress risk profile for each patient newly admitted to the cancer centre. The instrument contains physical, emotional, social and familial aspects of distress. If necessary a psycho-oncologist was summoned for a detailed diagnostic and, when required, for further psycho-oncological support. At the University Hospital rechts der Isar, Munich, all patients with a visceral tumor are discussed in a daily interdisciplinary conference, so called "tumorboard", to develop an individual treatment plan. The risk profile generated with the PO-K was part of the information and findings which were presented in the tumorboard for each patient and was considered in the individual treatment planning. Additionally, psycho-oncologists of the study group participated in the daily tumorboard to follow treatment decisions and answer questions about the psychosocial condition of study patients. Patients self-assessment was correlated with the doctors distress profile as well as with the psycho-oncologists expertise, to see if medical doctors were able to detect psychosocial risk factors. Experiences about the implementation of the screening in the context of the interdisciplinary tumorboard will be reported and data about the accordance of patients self report, medical doctor screening and psycho-oncological diagnostics of 269 patients will be presented. *The project is funded by the Deutsche Krebshilfe eV.